vaccinia virus
Showing 1 - 25 of 6,485
Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)
Not yet recruiting
- Advanced Solid Tumors
- Recombinant human IL-21 oncolytic vaccinia virus injection
-
Hangzhou, Zhejiang, China
- +1 more
Jun 21, 2023
Oncolytic Virotherapy Trial in St. Petersburg (Double Recombinant Vaccinia Virus VV-GMCSF-Lact)
Recruiting
- Oncolytic Virotherapy
- Double Recombinant Vaccinia Virus VV-GMCSF-Lact
-
St. Petersburg, Russian FederationN.N. Petrov National Medical Research Center of Oncology
May 11, 2022
Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (VAC?6 vaccine - ?nce at a dose of 106 PFU, VAC?6 vaccine - once at a dose of
Completed
- Smallpox
- +3 more
- VAC∆6 vaccine - оnce at a dose of 10⁶ PFU
- +3 more
-
Novosibirsk, Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Healthcare Institution - Medical and San
Feb 28, 2023
Healthy, Communicable Diseases Trial (Vaccinia Immune Globulin (Human))
Withdrawn
- Healthy
- Communicable Diseases
- Vaccinia Immune Globulin (Human)
- (no location specified)
Oct 28, 2021
Lung Cancer Trial in New York (GL-ONC1)
Active, not recruiting
- Lung Cancer
- GL-ONC1
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 7, 2022
HIV Trial in Rochester (HIVAC-1e, gp160 Vaccine (MicroGeneSys))
Completed
- HIV Infections
- HIVAC-1e
- gp160 Vaccine (MicroGeneSys)
-
Rochester, New YorkUniv. of Rochester AVEG
Oct 26, 2021
Smallpox, Monkeypox, Cowpox Trial in Koltsovo, Novosibirsk (VAC?6 vaccine (107 PFU), VAC?6 vaccine (106 PFU), Live Smallpox
Completed
- Smallpox
- +3 more
- VAC∆6 vaccine (10⁷ PFU)
- +3 more
-
Koltsovo, Novosibirsk Region, Russian Federation
- +1 more
Apr 25, 2023
Relapsed or Refractory B-cell Lymphoma Trial in Hangzhou (RGV004)
Not yet recruiting
- Relapsed or Refractory B-cell Lymphoma
- RGV004
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 30, 2021
Renal Cell Carcinoma Trial in Australia, Korea, Republic of, United States (Pexastimogene Devacirepvec (Pexa-Vec), Cemiplimab)
Active, not recruiting
- Renal Cell Carcinoma
- Pexastimogene Devacirepvec (Pexa-Vec)
- Cemiplimab
-
Irvine, California
- +17 more
Oct 26, 2022
Ovarian Cancer Trial in Wuhan (KM1, Chemotherapy)
Not yet recruiting
- Ovarian Cancer
- KM1
- Chemotherapy
-
Wuhan, Hubei, ChinaTongji Hospital of Tongji Medical College, Huazhong University o
Jan 5, 2023
Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA
Recruiting
- Lynch Syndrome
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
- +2 more
-
Duarte, California
- +3 more
Nov 22, 2022
Local Progression or Metastatic Melanoma With Failed First-line Treatment Trial in Beijing (Pexa-Vec combined with ZKAB001,
Recruiting
- Local Progression or Metastatic Melanoma With Failed First-line Treatment
- Pexa-Vec combined with ZKAB001
- ZKAB001 monotherapy
-
Beijing, ChinaBeijing Cancer Hospital
Mar 30, 2022
HIV Trial in Saint Louis, Pittsburgh, Nashville (gp160 Vaccine (Immuno-AG))
Completed
- HIV Infections
- gp160 Vaccine (Immuno-AG)
-
Saint Louis, Missouri
- +2 more
Oct 27, 2021
HIV, HIV Seronegativity Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))
Completed
- HIV Infections
- HIV Seronegativity
- gp160 Vaccine (Immuno-AG)
-
Saint Louis, Missouri
- +1 more
Oct 28, 2021
HIV Trial in Saint Louis, Rochester, Nashville (gp160 Vaccine (Immuno-AG))
Completed
- HIV Infections
- gp160 Vaccine (Immuno-AG)
-
Saint Louis, Missouri
- +2 more
Oct 28, 2021
Hepatocellular Carinoma Trial in Korea, Republic of, Spain, United States (JX-594 recombinant vaccina GM-CSF)
Completed
- Hepatocellular Carinoma
- JX-594 recombinant vaccina GM-CSF
-
Scottsdale, Arizona
- +4 more
Dec 29, 2020
HIV Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))
Completed
- HIV Infections
- gp160 Vaccine (Immuno-AG)
-
Saint Louis, Missouri
- +1 more
Oct 28, 2021
Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos.HIV
- +2 more
-
Bangkok, Thailand(unnamed)
Dec 29, 2021
Monkeypox Virus Infection Trial in Boende (IMVAMUNE)
Active, not recruiting
- Monkeypox Virus Infection
- IMVAMUNE
-
Boende, Tshuapa, Congo, The Democratic Republic of theTshuapa site
May 11, 2022
Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus
Active, not recruiting
- Adult Solid Neoplasm
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Advanced Malignant Solid Tumors Trial in Shenyang, Shanghai (T601, T601+5-FC)
Recruiting
- Advanced Malignant Solid Tumors
- T601
- T601+5-FC
-
Shenyang, Liaoning, China
- +1 more
Dec 4, 2020
Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)
Recruiting
- Cytomegalovirus Infections
- +2 more
- CMV-MVA Triplex
- Placebo
-
Birmingham, Alabama
- +11 more
Jun 20, 2022
Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,
Recruiting
- Cutaneous Squamous Cell Carcinoma
- +18 more
- MQ719
- Pembrolizumab
-
Basking Ridge, New Jersey
- +6 more
May 18, 2023
Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,
Completed
- Smallpox
- +3 more
- NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
- +5 more
-
Novosibirsk, Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Healthcare Institution - Medical and San
Jul 27, 2023
Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos4.HIV
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 7, 2022